In early stages of AD, DAM cells can be useful, removing Aβ aggregates in triggering receptor expressed on myeloid cells 2 (TREM2)-dependent manner (Keren-Shaul et al., 2017; Ulland and Colonna, 2018). This evidence concerns the gene TREM2 and Alzheimer disease.